Clinical trial
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
NCT02631616 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- February 29, 2016
- Completion date
- March 31, 2018
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.